Viveon Health Acquisition Corp. (VHAQ)
OTCMKTS: VHAQ · Delayed Price · USD
10.00
0.00 (0.00%)
Apr 19, 2024, 10:21 AM EDT - Market open
Company Description
Viveon Health Acquisition Corp. does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America.
The company was incorporated in 2020 and is based in Atlanta, Georgia. Viveon Health Acquisition Corp. operates as a subsidiary of Viveon Health LLC.
Viveon Health Acquisition Corp.
| Country | GA |
| Founded | 2020 |
| IPO Date | Dec 23, 2020 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Dr. Jagi Gill M.D., Ph.D. |
Contact Details
Address: 3480 Peachtree Road Ne, 2nd Floor - Suite #112 Atlanta, Georgia 30326 United States | |
| Phone | 4045797978 |
Stock Details
| Ticker Symbol | VHAQ |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001823857 |
| CUSIP Number | 92853V106 |
| ISIN Number | US92853V1061 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jagi Gill M.D., Ph.D. | Chief Executive Officer, President and Chairman of the Board |
| Dr. Romilos Papadopoulos M.D. | Chief Financial Officer, Treasurer, Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 1, 2024 | 425 | Filing |
| Apr 1, 2024 | 8-K | Current Report |
| Mar 29, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Mar 27, 2024 | 425 | Filing |
| Mar 27, 2024 | 8-K | Current Report |
| Mar 15, 2024 | 25-NSE/A | Filing |
| Mar 4, 2024 | UPLOAD | Filing |
| Mar 1, 2024 | DEF 14A | Other definitive proxy statements |
| Feb 27, 2024 | 425 | Filing |
| Feb 27, 2024 | 8-K | Current Report |